CD274 and non-small cell lung carcinoma: Some studies have even reported that AI-assisted methods, such as the evaluation of pretreatment contrast-enhanced CT images, PD-L1 expression, or the spatial analysis of TIL, can yield better predictions of survival outcomes in NSCLC patients undergoing IO treatment [33–35].